3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Carcinoma, Hepatocellular
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
5
Breast Neoplasms
5
Melanoma
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Astrocytoma
2
Adenomatous Polyposis Coli
2
Thyroid Neoplasms
1
Thrombocytosis
1
Somatostatinoma
1
Sarcoma, Clear Cell
1
Retinoblastoma
1
Interventions
Cisplatin
8
Carboplatin
8
X-Rays
7
Specimen Handling
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
sodium thiosulfate
5
Vincristine
5
Nuclear Medicine Department, Hospital
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Doxorubicin
5
Biopsy
5
Melphalan
4
Irinotecan
4
Fluorouracil
4
fludarabine
3
Thiotepa
3
Oxaliplatin
3
Mesna
3
Gemcitabine
3
Filgrastim
3
Busulfan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Sirolimus
×
Gastrointestinal
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled